Overactive Bladder Syndrome Clinical Trial
Official title:
The Effect of Position (Sit/Stand up vs Supine Position) on Urge Sensation in Volunteers and in Patients With Overactive Bladder Syndrome
NCT number | NCT00821314 |
Other study ID # | MEC 08-2-128.3 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | January 12, 2009 |
Last updated | June 15, 2010 |
Start date | April 2009 |
Importance of the problem OAB is a common health problem. Milsom et al. [1] randomly
selected a population from six European countries. From this population, 17% of the
respondents reported having OAB symptoms with 14% reporting frequency, 9% urgency, and 6%
urge incontinence. The study by Milsom et al. [1] showed that OAB adversely affected the
lives of the majority (65%) of the respondents who reported OAB symptoms. Chen et al. [2]
also reported that the prevalence of OAB in Taiwanese women was similar to that of Western
women. In the study of Chen et al.[2], the prevalence of OAB was 18.6% for the patients;
perceptions and the number of OAB condition significantly increased in the elderly women
(over 65 years old, 39.3%). Apart from impairing the physical health, OAB may have a
tremendous effect on psychological and social well-being. Information on the symptoms and
disease severity can yield important information that often complements objective measures.
Incontinence, increased urge and increased frequency of micturition affect nearly 100
million people in the western world (33 million in the US and 66 million in the European
Union). These conditions are not life threatening but they seriously affect quality of life
and ability to work. OAB is in some studies reported to have an incidence of up to 17 % in
the western population with great consequences for the quality of life.
Economic cost The total economic cost of this group of conditions is high. In 2002 the costs
in the US were approximately $12.7 billion[1] (estimated to be $17 billion and €22
billion/year in 2005). Approximately 25% of this expenditure is spent on treatment (drug
therapy, clinical consultation and surgery). Of those who suffer only 28% have sought help
and only half of those currently receive treatment. Less than 3% regain long lasting normal
control. Therefore, these costs are an under-estimate and the problem is large.
Aetiology
Status | Recruiting |
Enrollment | 100 |
Est. completion date | |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - OAB must be diagnosed by their urologist using the criteria of more than 8 micturitions on three consecutive days of these three days they keep a micturation diary with a VAS score for urge sensation. - Patients should have at least one episode of urge. Exclusion Criteria: - Patients with congestive heart disease and patients with a history of heart failure. - Patients with a post voiding residual volume of more than 100 cc. |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Netherlands | Maastricht University Hospital | Maastricht | Limburg |
Lead Sponsor | Collaborator |
---|---|
Maastricht University Medical Center |
Netherlands,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02540707 -
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
|
Phase 4 | |
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT06438861 -
Role of Combination Therapy in Women With Refractory Overactive Bladder
|
N/A | |
Completed |
NCT01114412 -
Basic Sensations Coming From the Bladder
|
||
Recruiting |
NCT06045728 -
Telerehabilitation for Overactive Bladder Syndrome in Obese Women
|
N/A | |
Recruiting |
NCT03952299 -
Oxybutynin for Post-surgical Bladder Pain and Urgency
|
Phase 3 | |
Active, not recruiting |
NCT03758235 -
Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin
|
Phase 3 | |
Completed |
NCT01912885 -
Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome
|
N/A | |
Completed |
NCT04300400 -
Treatment of the Overactive Bladder Syndrome: A Delphi Study
|
||
Recruiting |
NCT04982120 -
Use of Repris Needle in Bladder Injection
|
N/A | |
Completed |
NCT06123364 -
Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder
|
N/A | |
Recruiting |
NCT06088394 -
Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder
|
N/A | |
Recruiting |
NCT05221021 -
Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome
|
Phase 4 | |
Terminated |
NCT04256876 -
TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)
|
N/A | |
Not yet recruiting |
NCT03331081 -
Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome
|
N/A | |
Recruiting |
NCT04873037 -
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
|
N/A | |
Completed |
NCT02024945 -
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
|
Phase 4 | |
Completed |
NCT00546637 -
Fesoterodine "add-on" Male Overactive Bladder Study
|
Phase 3 | |
Not yet recruiting |
NCT06143397 -
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
|
N/A | |
Recruiting |
NCT03044912 -
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
|
Phase 3 |